Delivery Order SPE2DB25D7068-SPE2DB25FTWMS
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.14 firm fixed-price delivery order is for the supply of MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a period of performance through March 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $10,459.32 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Medroxyprogesterone 150 mg/mL. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,659.02, is for the delivery of Medroxyprogesterone 150 mg/mL, a pharmaceutical product. The contract has a delivery order type and firm fixed price pricing structure, with a performance period ending on May 22, 2023. The contract is not designated as a set-aside and was awarded through full and...
This federal contract award, valued at $1,192.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of medroxyprogesterone 150 mg/ml, a pharmaceutical product, to support federal healthcare programs. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,584.08 firm-fixed-price delivery order is for the supply of 4566764107 MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a period of performance through December 20, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of medroxyprogesterone 150 mg/ml. The award, valued at $7,753.13, was issued as a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of medroxyprogesterone 150 mg/ml medical products. The $2,148.29 fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 10, 2022. The contract is not designated with a set-aside. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,425,004 units of medroxyprogesterone 150 mg/ml, a prescription medication. The contract is a Delivery Order valued at $1,155.89 with a firm fixed price and an ultimate completion date of August 13, 2024. This contract is not associated with a set-aside program. Amerisourcebergen is the prime...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,419.96 contract is for the supply of Medroxyprogesterone 150 mg/mL, a medication used in various medical treatments. The contract has a period of performance through September 26, 2023 and is a firm fixed-price contract. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $1,680.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order for the supply of MEDROXYPROGESTERONE 150 MG/ML, a medication, with a completion date of December 21, 2023. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov)...